Insmed (INSM) Preferred Dividend Payments (2011)

Insmed's (INSM) quarterly Preferred Dividend Payments came in at -$9.2 million in Q1 2011.

Insmed (INSM) Preferred Dividend Payments (2011) Analysis & Trends

Insmed's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at -$9.2 million for Q1 2011.

On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$9.2 million in Q1 2011; TTM through Dec 2011 was -$9.2 million, a N/A change from a year earlier, with the FY2011 full-year figure at -$9.2 million, changed N/A from the prior year.
Preferred Dividend Payments held at -$9.2 million in Q1 2011 per INSM's latest filing.
Across five years, Preferred Dividend Payments topped out at -$9.2 million in Q1 2011 and bottomed at -$9.2 million in Q1 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Insmed	23.02 Bn	21.80 Bn	258.54 Mn	-

Download Data

Date	Value
Mar 31, 2011	-9.18 Mn